#FLNA Filana Therapeutics to Participate in the 2026 Maxim Growth Summit

https://www.stocktitan.net/news/FLNA/filana-therapeutics-to-participate-in-the-2026-maxim-growth-voixifvruxva.html?utm_source=stocktitan-bluesky&utm_medium=social

🟢 $FLNA — Barry Richard, President & CEO
BOUGHT: 206,813 shares @ $0.90
Total: $186K
Filed Sep 28, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/FLNA

#InsiderTrading #FLNA #StockMarket

🚨$FLNA +38% premarket! FDA lifted its clinical hold on simufilam for TSC-related epilepsy — clearing the path to finally start the trial. Formerly Cassava Sciences, now repositioned for a rare seizure disorder. Analysts: Buy, PT $6.50 (+779%!). High risk, high history. 🧬⚖️ @FilanaTx #FLNA #TSC #Biote

🚨 JUST IN: $FLNA
FDA lifts clinical hold on Filana's simufilam, enabling Phase 2a trial for TSC-related epilepsy

#SEC #stocks #investing #FLNA #Regulatory
🔗 secwatch.observer

#FLNA Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy

https://www.stocktitan.net/news/FLNA/filana-therapeutics-announces-fda-lift-of-clinical-hold-on-simufilam-oxkb4t0igmoj.html?utm_source=stocktitan-bluesky&utm_medium=social